 |
November 2004 |
"ISPOR
e-BULLETIN" provides updates of recent ISPOR activities and events. For
detailed information on ISPOR activities, members are encouraged to go to www.ispor.org.
NEW THIS MONTH
**NEW**
ISPOR CONNECTIONS, Vol. 10 No. 5 September/October 2004
**NEW**
7TH ANNUAL EUROPEAN CONGRESS PHOTO GALLERY
**NEW**
PATIENT REGISTRY SIG
SURVEY & RETROSPECTIVE DATABASE SIG
**NEW**
ISPOR SEVENTH ANNUAL EUROPEAN CONGRESS CONTRIBUTED PAPER AWARDS RECIPIENTS
**NEW**
LAUNCH OF
ISPOR EUROPEAN STUDENT CHAPTER
**NEW** 13 NEW POSITIONS AT ISPOR EMPLOYMENT WEBSITE
**NEW**
ISPOR BOARD OF
DIRECTORS CALL FOR NOMINATIONS
**NEW**
ISPOR AWARDS
CALL FOR NOMINATIONS
ISPOR ONGOING ACTIVITIES
1.
Publications
2.
Meetings and Congresses
3.
Educational Activities
4.
Student News
5.
ISPOR Special Interest Groups
6.
Committee and Task Force Activities
7.
Hot Topics
8.
Important Dates to Remember
9.
Employment in Pharmacoeconomics and Outcomes Research
10.
Membership
- PUBLICATIONS
Top
VALUE IN HEALTH
Value in Health: Volume 7, Issue 5, September/October
2004 is online and available this month:
http://www.ispor.org/valueinhealth_index.asp.
Value in Health: Volume 7, September 2004 Special
Issue is online and available this month:
http://www.ispor.org/valueinhealth_index.asp.
Value in Health: Volume 7, Issue 6, November/December
2004, which includes the 7th Annual European Congress abstracts, is
online and available this month at:
http://www.ispor.org/valueinhealth_index.asp.
ISPOR CONNECTIONS
ISPOR CONNECTIONS: Volume 10, Issue 5, September/October
2004 is available online to the public at:
http://www.ispor.org/news/index_new.asp.
In this issue:
Use and Misuse of the Case-Control Methodology in Economic Analyses
J. Jaime Caro, 1Caro
Research Institute, Concord, MA, USA; and
Krista F. Huybrechts, McGill University, Montreal, Quebec, Canada
The Continuing
Evolution of Patient Registries: Designing Programs to Meet Broad
Organizational Objectives
Leanne
Larson, Ovation Research Group, Highland Park, IL, USA and Peter Malamis,
Synthesis, Springfield, VA, USA
Issues in the Use of
Patient Reported Outcomes in Medical Device Trials: A Report on the “ISPOR
Medical Device Forum: Patient Reported Outcomes (PROs) in Device Evaluation:
Scientific and Regulatory Challenges”, May 18, 2004, Arlington, VA, USA
Nancy Kline Leidy, PhD, MEDTAP
International, Bethesda, MD, USA
President’s Fireside Chat
Lieven Annemans, MSc, PhD, 2004-2005
ISPOR President
Let’s Get Talking…New
Initiatives to Facilitate Communication Among ISPOR Researchers
Elinor Chumney, PhD, Chair of the MC_PBM Research Network
Working Group and Assistant Professor, Medical
University of South
Carolina, Charleston,
SC, USA
ISPOR Avedis
Donabedian Outcomes Research Lifetime Achievement Awardee:
Michael F. Drummond PhD
HEALTH CARE COST, QUALITY, AND OUTCOMES: ISPOR BOOK OF TERMS
This ISPOR publication includes more than 100 detailed
monographs covering over 400 terms used in health care delivery, management,
and regulation, as well as health care outcomes research including clinical,
economic, and quality-of-life research terms. ISPOR member discounted price is $36.00;
a 40% discount! Student/Library/Academic discounted price: $33.00
(a 45% discount). On-line ordering is now available at:
http://www.ispor.org/publications/lexicon_index.asp.
Contact Stephen Priori at
spriori@ispor.org for information on
orders over 1000.
- ISPOR MEETINGS
AND CONGRESSES
Top
10TH ANNUAL INTERNATIONAL MEETING
May 15-18, 2005, Marriott Wardman Park
Hotel, Washington, DC, USA
CALL FOR ABSTRACTS AVAILABLE ONLINE
http://ispor.confex.com/ispor/intl2005/
SUBMIT YOUR ABSTRACT NOW!
Abstract
Deadline: 10 January 2005
Early
Registration Deadline: 19 April 2005
MEETING AT A GLANCE
http://www.ispor.org/meetings/washington0505/index.asp
Sign up for Exhibit Space, contract
available online a
https://www.ispor.org/Exhibit_Sponsor/ExhibitorOpportunities.aspx?event=2
Sponsorship Opportunities still available, for more
information go to
https://www.ispor.org/Exhibit_Sponsor/SponsorshipOpportunities.aspx?event=2
7TH ANNUAL EUROPEAN CONGRESS
24-26 October 2004, CCH Congress Centrum Hamburg, Hamburg, Germany
Photo Gallery **NEW**
http://www.ispor.org/congresses/germany1004/photogallery/pages/default.asp
- EDUCATION
ACTIVITIES
Top
ISPOR SHORT COURSES
-prior to the ISPOR 10TH
Annual International Meeting
**For short course descriptions and instructor
information please go to:
Saturday, May 14th:
http://www.ispor.org/meetings/washington0505/sc14.asp
Sunday, May 15th:
http://www.ispor.org/meetings/washington0505/sc15.asp
SATURDAY, MAY 14, 2005
Pharmacoeconomics
Pharmacoeconomics for Decision-makers - Full Day Course (8:00am-5:00pm)
Clinical Assessment
Retrospective Database Analysis: Data sources and Methods - Full Day Course
(8:00am-5:00pm)
Modeling
Bayesian Analysis: Overview - Morning Course
(8:00am-12:00pm)
Modeling
Bayesian Analysis: Applications - Afternoon
Course (1:00pm-5:00pm)
Quality of Life/Patient-reported Outcomes
Introduction
to Quality of Life/Patient-Reported Outcomes - Afternoon Course
(1:00pm-5:00pm)
Economic Analysis-
Financial Impact / Cost of Illness - Afternoon
Course (1:00pm-5:00pm)
SUNDAY
, MAY 15, 2005
Modeling
Modeling: Structure & Design of Model - Full Day Course (8:00am-5:00pm)
Pharmacoeconomics
Elements of Pharmaceutical Pricing -
Morning
Courses (8:00am-12:00pm)
Economic
Analysis
Cost Estimation: Finding and Extracting Cost
Data - Morning Courses (8:00am-12:00pm)
Quality of Life /
Patient-reported Outcomes
Old and New Utility Measures in Health
Economics and Outcomes Research - Morning Courses (8:00am-12:00pm)
Clinical Assessment
Meta-Analysis and Systematic Literature Review -
Morning
Courses (8:00am-12:00pm)
Economic Analysis
Statistical Considerations In Economic
Evaluations - Afternoon Courses (1:00pm-5:00pm)
Quality of Life/Patient-reported Outcomes
Advanced Quantitative Methods for Quality of Life/Patient-reported Outcomes
Research
-
Afternoon Courses (1:00pm-5:00pm)
Decision Analysis
Introduction to Decision Analysis
- Afternoon Courses
(1:00pm-5:00pm)
ISPOR Distance Learning
Program at the ISPOR website:
http://www.ispor.org/distancelearning/index.asp
The following module topics are available:
Pharmacoeconomics
Pharmacoeconomic Evaluations & Methods
Cost-Effectiveness Analysis
Cost-Benefit Analysis
Cost-Utility Analysis
Humanistic Outcomes (Utilities, Health-related Quality of Life, Patient-reported Outcomes, Patient Preferences)
Study Design in Pharmacoeconomics
Guidelines and Reference Standards
- STUDENT
NEWS
Top
**NEW**
LAUNCH OF
ISPOR EUROPEAN STUDENT CHAPTER
The launch of the ISPOR European Student Chapter
(ESC) during the Student Forum at the ISPOR 7th Annual European
Congress in Hamburg, Germany was a great success. Special
thanks to Larry Humble, Student Network chair, and Zeba Khan, Student Network Advisor,
for all their hard work.
For more details on the ISPOR Student Network, please
visit:
http://www.ispor.org/student/student_index.asp
- ISPOR
SPECIAL INTEREST GROUPS (SIG)
Top
PATIENT REGISTRY SIG
**NEW** Let us know what you think… in less than 5 minutes!
Participate the Patient Registry SIG Survey! The Patient Registry SIG is conducting
this brief survey to gain a better understanding of the needs of users of
patient registry information. The results will enable the SIG and the
Working Groups to focus specifically on activities that will have the greatest
benefit to the outcomes research community and users of outcomes research
information derived from patient registries.
For survey
link and more details, please visit:
http://www.ispor.org/sigs/patient_registr.asp
RETROSPECTIVE DATABASE
SIG
**NEW**
Chairs, Mission,
Goals & Working Groups
Co-Chairs:
Michael Johnson PhD, Houston Center for Quality of Care and Utilization
Studies, Michael E. DeBakey VA Medical Center, Assistant Professor of Medicine,
Baylor College of Medicine
William D. Marder PhD, Senior Vice President
& General Manager, Medstat
MISSION: To provide an international forum for
ISPOR membership to identify and address comprehensive issues in the development and use of retrospective clinical, survey
and administrative databases for pharmacoeconomic outcomes research.
GOALS: Identify main issues, including determining standards, best
practices or gaps that exist in identified areas. Form workgroups to address the state of the
art in each area, producing peer reviewed literature,
dissemination of standards and policy recommendations as feasible and appropriate.
WORKING GROUPS:
Classification of Databases
- who, what, where of US, Canadian, European, International
clinical, survey, and administrative healthcare
databases
Policy Advocacy - how research using these sources of information can
inform policy decision-making.
Research Design & Analysis – collect state of the art and future
directions on issues of research design and statistical analysis.
Database Development –
represent researcher needs in discussion with public and private database developers as they address data release and other
policy concerns.
Privacy Regulations - impact of HIPAA and other levels
of regulation on current and future practice.
For more
details on this SIG, please visit:
http://www.ispor.org/sigs/retrospective_db.asp
MEDICATION COMPLIANCE SIG
Forum at the 7th European
Congress:
Issues in Medication Compliance and
Persistence Research:
The forum examined major applied research issues important for the assessment of
medication compliance/adherence/persistence. The discussion reviewed the
definitions, methods of analyses, economic impact, and educational components
currently under development by the
SIG. Panelists discussed the approaches with comments and suggestions to help
move ISPOR into the forefront of medication analyses and enhancements.
For more details on
this SIG, please visit:
http://www.ispor.org/sigs/medication.asp
QUALITY OF LIFE SIG
Forum at the 7th European
Congress: Industry
and Regulatory Perspectives on Translating Patient Reported Outcome (PRO)
measures
The forum compared and contrasted different
approaches to translation and cultural validation of instruments prior to their
use in clinical trials. Speakers
discussed the potential costs and benefits of these approaches, including their
implications for bias and precision of results; and provided regulatory perspectives
on issues such as the role of certification and validation requirements for
multinational trials.
For more details on this SIG, please visit:
http://www.ispor.org/sigs/qol.asp
HEALTH TECHNOLOGY
ASSESSMENT SIG
For more details on this SIG, please visit
http://www.ispor.org/sigs/hta.asp
RISK MANAGEMENT SIG
For more details on this SIG, please visit:
http://www.ispor.org/sigs/rm.asp
MANAGED
CARE_PBM SIG
For more details, please visit
http://www.ispor.org/sigs/mc_pbm.asp
CLINICAL PRACTICE SIG
For more details, please visit:
http://www.ispor.org/sigs/cp.asp
Special
Interest Group membership is open to ALL ISPOR members.
To JOIN
any SIG:
http://www.ispor.org/sigs/joinsig.asp
- ISPOR BOARD,
COMMITTEE, AND TASK FORCE ACTIVITIES
Top
**NEW**ISPOR
2005-2006 BOARD OF DIRECTORS CALL FOR NOMINATIONS
ISPOR is a member-driven
organization. As a member-driven
organization, its governance is determined by the membership. The ISPOR Nominations Committee is seeking
qualified candidates for the position of PRESIDENT-ELECT and 2 DIRECTOR
positions.
You, as an ISPOR member, are
invited to submit your name if you wish to be considered for a position on the
ISPOR BOARD OF DIRECTORS. You may also
recommend the name of another ISPOR member.
Please email your interest or recommendation to:
nominations@ispor.org.
Please attach a curriculum
vitae. The deadline for submitting
nominations is Monday, February 2, 2005.
AWARD
COMMITTEE ACTIVITIES
**NEW** ISPOR SEVENTH ANNUAL EUROPEAN CONGRESS CONTRIBUTED PAPER AWARDS RECIPIENTS
BEST CONTRIBUTED PAPER AWARDS PODIUM PRESENTATIONS
GENERAL
CV1
A HEALTH ECONOMIC EVALUATION OF ASPIRIN IN THE
PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE
Lamotte M1, Annemans L1,
Evers T2, Kubin M3
1HEDM, Meise,
Belgium; 2Bayer
Vital GmbH, Leverkusen, Germany; 3Bayer HealthCare, Wuppertal, Elberfeld,
Germany
CV3
NURSING HOME RESIDENTS WITH STROKE: CHANGES IN
MANAGEMENT LEVELS AND COSTS OVER A SIX YEAR PERIOD
O'Brien JA, Duran P, Caro JJ
Caro
Research Institute, Concord,
MA, USA
DB3
DECREASED RATES OF MAJOR HYPOGLYCAEMIC EVENTS LEAD
TO IMPROVED LONG TERM COST EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30/70
VERSUS BIPHASIC HUMAN INSULIN 30 IN TYPE 2 DIABETIC SUBJECTS IN DANISH,
FINNISH, GERMAN, NORWEGIAN, SPANISH, SWEDISH, AND UK SETTINGS
Lammert M1, Palmer AJ2,
Roze S2, Minshall ME3, Valentine WJ2
1Novo Nordisk A/S,
Bagsvaerd, Denmark; 2CORE Center for Outcomes Research,
Binningen/Basel, Switzerland; 3CORE-USA, Fishers, IN, USA
NEW INVESTIGATOR
HP4
DRUG COSTS DEVELOPMENT AFTER PATENT EXPIRY IN THE
NETHERLANDS
Boersma C, Bos JM, Klok RM,
Postma MJ
Groningen
University Institute for Drug Exploration / University of Groningen Research
Institute of Pharmacy (GUIDE/GRIP), Groningen, Groningen, The Netherlands
QL7
VALIDATION OF A PATIENT-ADMINISTERED QUESTIONNAIRE
TO MEASURE THE SEVERITY OF LOWER URINARY TRACT SYMPTOMS IN UNCOMPLICATED
URINARY TRACT INFECTION: THE UTI SYMPTOM ASSESSMENT (USA) QUESTIONNAIRE
Clayson DJ1, Wild DJ1, Keating K2,
Gondek K2
1Oxford
Outcomes Ltd, Oxford, Oxon, UK; 2Bayer HealthCare Pharmaceuticals,
West Haven, CT, USA
UC4
VARIATION IN ADL FUNCTIONING WITHIN BARTHEL INDEX
SCORES:IMPLICATIONS FOR STROKE CLINICAL TRIALS AND PRACTICE
Banks JL1, Netten A2,
Pollok J3, Van de Peer L3, Salas M4
1Health Outcomes
Strategy Group, Boston, MA, USA; 2University of Kent at Canterbury,
Canterbury, UK; 3Kent and Canterbury Hospital, Canterbury, UK; 4Erasmus
University Medical School, Rotterdam, The Netherlands
STUDENT
HP3
PHARMACOECONOMIC EDUCATION AT NON-US COLLEGES OF
PHARMACY
Nwokeji ED, Rascati K
The University of Texas
at Austin, Austin, TX, USA
BEST CONTRIBUTED PAPER AWARDS POSTER
PRESENTATIONS
GENERAL
PCN42
POOLING CLINICAL AND COST OUTCOMES: A CASE STUDY OF BEST SUPPORTIVE CARE (BSC)
IN ADVANCED NON SMALL CELL LUNG CANCER (NSCLC)
McAllister R1, Meddis D2, Jansen J1, Ryan J1,
Brown J2
1MAPI Values Ltd, Bollington, Cheshire, UK; 2AstraZeneca,
Macclesfield, Cheshire, UK
PCV27
COST-EFFECTIVENESS OF BUPROPION IN SMOKING CESSATION IN FINLAND
Hahl J, Jormanainen V
GlaxoSmithKline Oy, Espoo,
Finland
PES18
INTERPRETATION OF SCORES ON THE PSORIASIS INDEX OF QOL (PSORIQOL)
McKenna SP1, Meads DM1, Backhouse ME2
1Galen Research, Manchester, UK; 2Novartis Pharma AG, Basel, Switzerland
NEW INVESTIGATOR
PCN38
THE IMPACT OF SCREENING ADHERENCE ON MEDICAL EFFECTIVENESS AND
COST-EFFECTIVENESS OF CERVICAL CANCER SCREENING IN GERMANY – A DECISION ANALYSIS
Sroczynski G1, Voigt K2, Gibis B3, Aidelsburger P4,
Engel J5, Wasem J4, Hillemanns P5, Hölzel D5,
Goldie SJ6, Siebert U1
1Harvard Medical School, Boston, MA, USA; 2Institute for
Medical Informatics, Biostatistics, and Epidemiology, University of Munich,
Munich, Germany; 3National Association of Statutory Health Insurance
Physicians, Berlin, Germany; 4
University of Duisburg-Essen, Duisburg-Essen, Germany; 5
University of Munich, Munich, Germany; 6
Harvard School of Public Health, Boston, USA
PIN7
COST MINIMIZATION ANALYSIS OF ORAL VALGANCICLOVIR VS. INTRAVENOUS AND ORAL
GANCICLOVIR IN THE PREVENTION OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN SOLID
ORGAN TRANSPLANT RECIPIENTS
Rubio M1, Oppenheimer F2, Magaz S1, Badia X1
1Health Outcomes Research Europe, Barcelona, Barcelona, Spain; 2Hospital
Clinic I Provincial de Barcelona, Barcelona, Spain
PIN10
COST-EFFECTIVENESS OF EXPANDED HIV SCREENING OF BLOOD DONATIONS IN GHANA
Van Hulst M1, Vermande J2, Sagoe K3,
Bos JM4, Postma MJ2
1University of Groningen / Martini Hospital, Groningen, Groningen,
Netherlands; 2University of Groningen, Groningen, Groningen,
Netherlands; 3University of Ghana Medical School, Accra, Accra,
Ghana; 4The Netherlands Vaccine Institute, Bilthoven, Utrecht,
Netherlands
STUDENT
PCV47
DECISION ANALYSIS ON EFFECTIVENESS AND COST-EFFECTIVENESS OF DISEASE MANAGEMENT
PROGRAMS FOR THE TREATMENT OF HEART FAILURE
Goehler A1, Dietz R1, Osterziel KJ1, Siebert U2
1Charitè Campus Virchow Klinikum, Berlin, Germany;
2Harvard Medical School, Boston, MA, USA
PCV63
OVER-ADHERENCE WITH ANTIHYPERTENSIVE MEDICATIONS AMONG CENTRAL TEXAS VETERANS
Yang M, Vincze G, Barner JC
The University of Texas at Austin, Austin, TX,
USA
PIN8
ECONOMIC EVALUATION OF HIV TREATMENTS: THE I.CO.N.A. COHORT STUDY
Merito M1, Baio G2, Bonaccorsi A3, Pammolli F4,
Riccaboni M4, Arici C5, D’Arminio Monforte A6,
Pezzotti P7, Corsini D8
1Sant’Anna School of Advanced Studies, Pisa, PI, Italy; 2University
of Florence, Florence, Italy, Italy; 3Sant’Anna School of Advanced
Studies, Italy; 4University of Florence, Italy; 5Ospedali
Riuniti – Bergamo, Italy; 6University of Milan, Italy; 7Istituto
Superiore di Sanità, Italy; 8Informa srl, Italy
**NEW** ISPOR RESEARCH EXCELLENCE AWARDS CALL FOR NOMINATIONS
The ISPOR Awards Committee is seeking nominees for both the
ISPOR Research Excellence Award for Methodology Excellence and Research
Excellence Award for Practical Application Excellence.
See
http://www.ispor.org/awards/methodology_.asp
and
http://www.ispor.org/awards/application_.asp
for Excellence Awards descriptions, criteria, selection process, nature of
award, and past recipients.
**NEW**
ISPOR BERNIE O’BRIEN NEW INVESTIGATOR AWARDS CALL FOR NOMINATIONS
The ISPOR Bernie O’Brien New Investigator Award was
established in 2004 to honor the long-standing commitment of Bernie J. O’Brien,
PhD to training and mentoring new scientists in the fields of outcomes research
and pharmacoeconomics. The award will be presented for the first time
at the ISPOR 10th Annual International
Meeting in Washington, DC, 15-18, 2005.
The ISPOR Awards Committee is seeking nominees for this
award. See
http://www.ispor.org/awards/Obrien_investigator.asp
for descriptions, criteria, selection process, and nature of the award.
The deadline to submit nominees for both
awards is FEBRUARY 15, 2005.
HEALTH
SCIENCE INITIATIVE: RCT-CEA TASK FORCE
The ISPOR 7th Annual European Congress hosted a
final RCT-CEA forum on Tuesday, October 26, 2004 The forum consisted of a slide
presentation presented by Co-chairs: Scott Ramsey, MD, PhD, Associate Member, Fred Hutchinson
Cancer Research
Center and Richard
Willke, PhD Senior Director, Group Leader, Global Outcome Research, Pfizer,
Inc.. After the presentation there was a
question and answer period presided over by the two co-chairs and Task Force
Core Group members: Andrew Briggs,
Dphil, University of Oxford, Health Economics Research Centre, Institute of
Health Sciences; Ruth Brown, MS, Director, MEDTAP Int’l, and Martin Buxton,
PhD, Professor, Brunel University, Health Economics Research Group. The forum was attended by approximately 120
Congress attendees. The final draft document
will be sent to all reference group members by mid-November and they will be
given an opportunity to comment. The
Final document will be published in the July-August 2005 Value in Health,
Volume 8, Issue 4.
- HOT TOPICS
Top
MEDICARE LAUNCHES EFFORTS
TO IMPROVE CARE FOR CANCER PATIENTS
NEW COVERAGE, BETTER EVIDENCE, AND
NEW SUPPORT FOR IMPROVING QUALITY OF CARE
WASHINGTON, D.C. – (November 1,
2004) – The Centers
for Medicare & Medicaid Services (CMS) today announced a set of new steps
to improve care for cancer patients by expanding coverage for screening tests
and treatments, developing better evidence on which treatments work best for
beneficiaries with cancer, and implementing a demonstration program to measure and
improve quality of care.
For full
text of the article, go to:
http://www.cms.hhs.gov/media/press/release.asp?Counter=1244
- IMPORTANT
DATES TO REMEMBER
Top
January 10, 2005 - Abstract Submission deadline for
the ISPOR 10th Annual International Meeting.
February 2,
2005 – Submission deadline for nominees for
ISPOR 2005-2006 Board of Directors positions.
February 15,
2005 – Submission
deadline for nominees for ISPOR Research Excellence Awards and Bernie J.
O’Brien New Investigator Award.
April 19,
2005 – Early
Meeting registration and hotel reservation deadline for the ISPOR 10th Annual International Meeting, Marriott Wardman Park Hotel, Washington, DC.
May 15-18 2005 – ISPOR 10th Annual
International Meeting, Marriott
Wardman Park Hotel, Washington,
DC.
June 20,
2005 – Abstract Submission deadline for the
ISPOR 8th Annual European Congress.
- EMPLOYMENT
Top
**NEW**
13 NEW POSITIONS AT THE ISPOR WEBSITE
http://www.ispor.org/employment/employment_index.asp
Advertise your positions on ISPOR
Website (1 million hits per month)
- ISPOR
MEMBERSHIP
Top
Update your email address at
https://www.ispor.org/members/addresschange.asp!
Your email address is required as part of your log in information in the
members only section of the ISPOR website.
eBulletin
Index
